Researchers analyzed data from more than 1 million women to determine if screening intervals could be safely extended with negative human papillomavirus tests compared with negative cytology screen results.
A meta-analysis sought to determine the rates of late-stage presentation among women with cervical cancer.
Odds of ever undergoing pap testing lower for non-Hispanic White and Hispanic SM participants versus non-Hispanic White heterosexuals.
An analysis of data from Mississippi sought to determine the rate of HPV infection and mortality from cervical cancer among women by race.
Researchers analyzed recent trends in cervical cancer incidence and mortality and made predictions for the next 15 years.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Among patients with a higher risk of metastasis, sentinel lymph node mapping had a sensitivity of 96.3%.
Genetic variations in the PAX8, CLPTM1L, and HLA genes were found to be associated with a high risk of developing cervical cancer.
A minority of women met criteria to exit cervical cancer screening.
This review discusses a consensus study on optimal management of tumor hypoxia in patients undergoing radiotherapy for cervical cancer.
